Delta-opioid receptor agonists inhibit neuromuscular transmission in human colon

Eur J Pharmacol. 1994 Sep 1;262(1-2):33-9. doi: 10.1016/0014-2999(94)90025-6.

Abstract

The present study was undertaken to investigate the possible role of delta-opioid receptors in the neuroregulation of human colonic motility by using a superfusion model. Spontaneous mechanical activity and responses to electrical transmural nerve stimulation of both longitudinal and circular muscle strips from the human sigmoid colon were studied. Exogenously added delta-opioid receptor agonists did not modify spontaneous contractile activities of either type of strip. Nerve stimulation induced a triphasic response composed of an initial contraction followed by a relaxation and an off-contraction. This response was mediated by cholinergic excitatory nerves and non-adrenergic, non-cholinergic excitatory and inhibitory nerves. [Met5]Enkephalin and the synthetic delta-opioid receptor agonist [D-Pen2,D-Pen5]enkephalin (DPDPE) significantly decreased the amplitude of the initial contraction and of the off-contraction. The effects of both delta-opioid receptor agonists were reduced in the presence of either the delta-opioid receptor antagonist, ICI 174864, or another delta-opioid receptor antagonist, naltrindole. ICI 174864 prevented neither the effects of a natural kappa-opioid receptor agonist, dynorphin-(1-13) nor those of the mu-opioid receptor agonist, PL017. Therefore, these data suggest that delta-opioid receptors might be involved in the neuroregulation of smooth muscle of human colon and may mediate inhibition of cholinergic and non-cholinergic excitatory transmission within the myenteric plexus.

Publication types

  • Comparative Study

MeSH terms

  • Analgesics / administration & dosage
  • Analgesics / pharmacology
  • Analgesics, Opioid / administration & dosage
  • Analgesics, Opioid / pharmacology
  • Colon / drug effects*
  • Colon / innervation
  • Dynorphins / pharmacology
  • Electric Stimulation
  • Endorphins / administration & dosage
  • Endorphins / pharmacology
  • Enkephalin, D-Penicillamine (2,5)-
  • Enkephalin, Leucine / administration & dosage
  • Enkephalin, Leucine / analogs & derivatives
  • Enkephalin, Leucine / pharmacology
  • Enkephalin, Methionine / administration & dosage
  • Enkephalin, Methionine / pharmacology
  • Enkephalins / administration & dosage
  • Enkephalins / pharmacology
  • Gastrointestinal Motility / drug effects
  • Humans
  • Muscle Contraction / drug effects
  • Muscle Relaxation / drug effects
  • Muscle, Smooth / drug effects*
  • Muscle, Smooth / innervation
  • Naltrexone / administration & dosage
  • Naltrexone / analogs & derivatives
  • Naltrexone / pharmacology
  • Narcotic Antagonists / administration & dosage
  • Narcotic Antagonists / pharmacology
  • Neuromuscular Junction / drug effects*
  • Peptide Fragments / pharmacology
  • Receptors, Opioid, delta / agonists*
  • Synaptic Transmission / drug effects*

Substances

  • Analgesics
  • Analgesics, Opioid
  • Endorphins
  • Enkephalins
  • Narcotic Antagonists
  • Peptide Fragments
  • Receptors, Opioid, delta
  • Enkephalin, Methionine
  • Enkephalin, Leucine
  • Naltrexone
  • dynorphin (1-13)
  • Dynorphins
  • morphiceptin, N-Me-Phe(3)-
  • Enkephalin, D-Penicillamine (2,5)-
  • N,N-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine
  • naltrindole